121 related articles for article (PubMed ID: 1694115)
41. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
42. Increased asialo-alpha-fetoprotein in patients with alpha-fetoprotein-producing tumors: demonstration by affinity electrophoresis with erythroagglutinating phytohemagglutinin of Phaseolus vulgaris lectin.
Taketa K; Ichikawa E; Akamatsu K; Ohta Y; Sekiya C; Namiki M; Takami H; Kaneda H; Higashino K; Taga H
Tumour Biol; 1985; 6(6):533-44. PubMed ID: 2426756
[TBL] [Abstract][Full Text] [Related]
43. Clinical aspects of alpha 1-fetoprotein determination in human liver cancer and in humans and experimental animals at carcinogenic risk.
Dolezalová V; Simícková M; Stratil P
J Toxicol Environ Health; 1979; 5(2-3):357-70. PubMed ID: 89199
[TBL] [Abstract][Full Text] [Related]
44. A microfluorometric immunoassay for the demonstration of human AFP.
Fiebach H; Micheel B
Arch Geschwulstforsch; 1980; 50(3):238-42. PubMed ID: 6159869
[TBL] [Abstract][Full Text] [Related]
45. Alpha-fetoprotein in the diagnosis of hepatoma.
Phillips P; Rowland R; Reid DP; Coles M
Br Med J; 1978 Nov; 2(6149):1432. PubMed ID: 82464
[No Abstract] [Full Text] [Related]
46. The diagnostic importance of alpha-fetoprotein.
Ojwang PJ
East Afr Med J; 1991 Aug; 68(8):593-4. PubMed ID: 1722451
[No Abstract] [Full Text] [Related]
47. Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Miédougé M; Salama G; Barange K; Vincent C; Vinel JP; Serre G
Clin Chim Acta; 1999 Feb; 280(1-2):161-71. PubMed ID: 10090533
[TBL] [Abstract][Full Text] [Related]
48. [Results of a 4-year of alpha-fetoprotein in Vietnam (1969--1973)].
Vu-trieu-An
Biull Eksp Biol Med; 1976 Feb; 81(2):224-5. PubMed ID: 58682
[TBL] [Abstract][Full Text] [Related]
49. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Raedle J; Roth WK; Oremek G; Caspary WF; Zeuzem S
Dig Dis Sci; 1995 Dec; 40(12):2587-94. PubMed ID: 8536517
[TBL] [Abstract][Full Text] [Related]
50. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
[TBL] [Abstract][Full Text] [Related]
51. Studies on human alpha-fetoprotein. Isolation and characterization of monomeric and polymeric forms and amino-terminal sequence analysis.
Yachnin S; Hsu R; Heinrikson RL; Miller JB
Biochim Biophys Acta; 1977 Aug; 493(2):418-28. PubMed ID: 70228
[TBL] [Abstract][Full Text] [Related]
52. Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.
Cao Q; Zhao X; Zhao Q; Lv X; Ma C; Li X; Zhao Y; Peng B; Ying W; Qian X
Anal Chem; 2014 Jul; 86(14):6804-11. PubMed ID: 24914453
[TBL] [Abstract][Full Text] [Related]
53. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Taketa K; Sekiya C; Namiki M; Akamatsu K; Ohta Y; Endo Y; Kosaka K
Gastroenterology; 1990 Aug; 99(2):508-18. PubMed ID: 1694805
[TBL] [Abstract][Full Text] [Related]
54. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
[TBL] [Abstract][Full Text] [Related]
55. Induction of hepatomas secreting large amounts of alpha-fetoprotein.
Smith CJ; Kelleher PC
Cancer Lett; 1977 Jul; 3(1-2):53-7. PubMed ID: 70269
[TBL] [Abstract][Full Text] [Related]
56. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
57. [Immunohistochemical studies in hepatocarcinomas].
Delfino MI; De Marco L; Simian S; Avagnina A; Elsner B
Medicina (B Aires); 1985; 45(3):235-9. PubMed ID: 2429135
[No Abstract] [Full Text] [Related]
58. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
[TBL] [Abstract][Full Text] [Related]
59. Alpha-Fetoprotein and hepatitis B antigen in hepatocarcinogenesis.
Sakurai M; Miyaji T
Ann N Y Acad Sci; 1975 Aug; 259():156-67. PubMed ID: 54018
[TBL] [Abstract][Full Text] [Related]
60. Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
Kohno T; Kitamura T; Tsuda K; Ishikawa E
J Clin Lab Anal; 1990; 4(1):74-8. PubMed ID: 1690279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
